In addition to P-gp, other adenosine triphosphate-binding cassette transporters, such as multidrug resistance-associated protein 1 and breast cancer resistance protein, have been implicated in MDR in osteosarcoma.[28] These transporters may contribute to drug efflux and resistance through overlapping or distinct substrate specificities.[29]. This evidence concerns the gene PGP and osteosarcoma.